English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

In order to biomimetic synthesize hydroxyapatite similar to natural bone. Hydroxyapatite (HAP) is biomimetic synthesized in simulated body fluid (SBF) by addition of imidazole-4,5-dicarboxylic acid grafted chitosan (IDACS). The effect of molar ratio of chitosan (CS) to imidazole-4,5-dicarboxylic acid (IDA) on preparation of HAP was investigated. The structure, size, and crystal phase of the obtained hydroxyapatite were observed by Fourier transform infrared spectroscopy, X-ray powder diffraction, and scanning electron microscopy. The results show that the molar ratio of CS to IDA is 1 : 3, the temperature is 37.0°C, the aging time is 48 h, the synthesized nanorod-like hydroxyapatite with diameter 20–30 nm, and length ranging from 75 to 120 nm presents excellent phase, which disperses well and is similar to the natural bone of HAP. The obtained HAP can be used to remove chromium(VI) by the orthogonal experiments, and the results indicated that the removal rate can reach 95.66% under the optimum conditions. These results suggest that the morphology of the obtained HAP is more affected by the material ratio of chitosan to imidazole-4,5-dicarboxylic acid than its structure, and the obtained HAP can effectively remove Cr(VI), which provides a novel method for biomimetic synthesis of other biomaterials and application in the water purification.

Biomimetic Synthesis of Hydroxyapatite in Presence of Imidazole-4,5-dicarboxylic Acid Grafted Chitosan for Removing Chromium(VI)